Dermatitis, Atopic Clinical Trials

A listing of Dermatitis, Atopic medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Fremont California 94538

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Santa Ana California 92701

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Georgia

UPDATED

Sandy Springs Georgia 30328

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Illinois

UPDATED

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Indiana

UPDATED

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

New Albany Indiana 47150

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Kentucky

UPDATED

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Texas

UPDATED

San Antonio Texas 78229

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Virginia

UPDATED

Norfolk Virginia 23507

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

Canada

UPDATED

Barrie Ontario L4M 7G1

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Markham Ontario L3P1X2

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Montreal Quebec H2K 4L5

A clinical trial seeking patients for a research study for the treatment of Dermatitis, Atopic

UPDATED

Montreal Quebec H2K 4L5

A clinical trial to evaluate treatments using ATx201 2% Cream and ATx201 Cream Vehicle for patients with Atopic Dermatitis

UPDATED

Oakville Ontario L6J 7W5

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

View More ▼

UPDATED

Peterborough Ontario K9J 5K2

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Quebec G1V 4X7

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Richmond Hill Ontario L4B 1A5

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Surrey British Columbia V3R 6A7

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic

UPDATED

Vancouver British Columbia V5Z 4E8

Patients are needed to participate in a clinical research study of Mepolizumab 100 mg and Placebo matching mepolizumab to evaluate Dermatitis, Atopic